Physician profile
Jose Vale
NPI 1235197799
$3,726.82
in general payments reported to CMS, 2019-2025
18 companies · $393 in 2025
The $393 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,193 · 2020: $371 · 2021: $853 · 2022: $275 · 2023: $250 · 2024: $392 · 2025: $393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,034.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $1,354.00 | 2019-2025 | Anastoclip Gc 8cm (Medium), Trivex System |
| Philips North America LLC | $644.25 | 2019-2023 | |
| Cardiovascular Systems INC. | $461.74 | 2019 | |
| Medtronic Vascular, INC. | $277.85 | 2019-2020 | |
| Endologix LLC | $243.39 | 2019-2020 | |
| Medtronic, INC. | $156.34 | 2021-2022 | |
| Abbott Laboratories | $140.51 | 2021-2024 | Jeti All In One Non-Sterile Kit, Supera, Esprit |
| Davol INC. | $127.04 | 2019 | |
| Mimedx Group, INC. | $90.48 | 2024-2025 | |
| W. L. Gore & Associates, INC. | $55.02 | 2021-2022 | |
| Incyte Corporation | $37.00 | 2025 | Jakafi |
| Janssen Pharmaceuticals, INC | $27.90 | 2019 | |
| Merck Sharp & Dohme LLC | $22.27 | 2025 | Keytruda, Keytruda Qlex |
| Conmed Corporation | $21.30 | 2022 | |
| Smith+Nephew, INC. | $21.00 | 2025 | Pico 7 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $17.04 | 2021 | |
| Baxter Healthcare | $15.44 | 2019 | |
| Medtronic USA, INC. | $14.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Vale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.